Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Trial Evaluating the Safety and Effectiveness of the remedē® System in Patients With Central Sleep Apnea

NCT01816776 is registered in ClinicalTrials.gov with Respicardia, Inc. as lead sponsor.

NCT NCT01816776
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01816776 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Trial Evaluating the Safety and Effectiveness of the remedē® System in Patients With Central Sleep Apnea
Lead sponsor
Respicardia, Inc.
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2013
Completion date
November 7, 2017
Enrollment
151 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, sleep apnea, central, sleep disordered breathing